KR100629670B1 - 산화 스트레스 저감 작용 조성물 - Google Patents
산화 스트레스 저감 작용 조성물 Download PDFInfo
- Publication number
- KR100629670B1 KR100629670B1 KR1020047005109A KR20047005109A KR100629670B1 KR 100629670 B1 KR100629670 B1 KR 100629670B1 KR 1020047005109 A KR1020047005109 A KR 1020047005109A KR 20047005109 A KR20047005109 A KR 20047005109A KR 100629670 B1 KR100629670 B1 KR 100629670B1
- Authority
- KR
- South Korea
- Prior art keywords
- coenzyme
- oxidative stress
- vivo
- reduced
- vitamin
- Prior art date
Links
- 0 C**(C)C(C(C(*)=C1OC)=O)=C(C)C1=O Chemical compound C**(C)C(C(C(*)=C1OC)=O)=C(C)C1=O 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Lubricants (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
소견 | 개체수 | |||
대조 | 환원형 보조효소Q10 | 산화형 보조효소 Q10 | VE | |
정상 | 0 | 0 | 0 | 0 |
랑게르한스섬 조직의 섬유화 1+ | 0 | 3 | 2 | 2 |
랑게르한스섬 조직의 섬유화 2+ | 4 | 1 | 2 | 2 |
Claims (3)
- 제 1 항에 있어서, 보조효소 Q 가 보조효소 Q10 인 조성물.
- 제 1 항에 있어서, 보조효소 Q 의 함유량이 0.001 내지 99 중량% 인 조성물.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001314932 | 2001-10-12 | ||
JPJP-P-2001-00314932 | 2001-10-12 | ||
PCT/JP2002/010641 WO2003032968A1 (fr) | 2001-10-12 | 2002-10-15 | Compositions destinees a reduire le stress oxydatif |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040041675A KR20040041675A (ko) | 2004-05-17 |
KR100629670B1 true KR100629670B1 (ko) | 2006-09-29 |
Family
ID=19133174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047005109A KR100629670B1 (ko) | 2001-10-12 | 2002-10-15 | 산화 스트레스 저감 작용 조성물 |
Country Status (11)
Country | Link |
---|---|
US (2) | US7015252B2 (ko) |
EP (1) | EP1435234B1 (ko) |
JP (1) | JPWO2003032968A1 (ko) |
KR (1) | KR100629670B1 (ko) |
CN (1) | CN1297262C (ko) |
AT (1) | ATE481095T1 (ko) |
AU (1) | AU2002338186B2 (ko) |
CA (1) | CA2461013C (ko) |
DE (1) | DE60237697D1 (ko) |
TW (1) | TWI329513B (ko) |
WO (1) | WO2003032968A1 (ko) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3742602B2 (ja) * | 2001-05-09 | 2006-02-08 | 株式会社カネカ | 還元型補酵素qの安定な溶液 |
TW200304372A (en) * | 2002-03-20 | 2003-10-01 | Kanegafuchi Chemical Ind | Compositions for diabetes |
TWI322008B (en) * | 2003-01-31 | 2010-03-21 | Kaneka Corp | Fatigue improving agent including reduced coenzyme q10 |
TW200524579A (en) * | 2003-11-28 | 2005-08-01 | Kaneka Corp | Composition for protecting liver functions |
US20050154066A1 (en) * | 2004-01-08 | 2005-07-14 | Kaneka Corporation | Antiaging composition |
CA2550186A1 (en) * | 2004-01-08 | 2005-07-21 | Kaneka Corporation | Antiaging composition |
JP2005200376A (ja) * | 2004-01-19 | 2005-07-28 | Nippon Menaade Keshohin Kk | 抗変異原性剤および抗変異原性食品 |
US7708990B2 (en) * | 2004-03-23 | 2010-05-04 | Kaneka Corporation | Coenzyme Q compositions persisting in blood |
AU2005224245A1 (en) * | 2004-03-23 | 2005-09-29 | Kaneka Corporation | Coenzyme Q composition with long-term persistence in blood |
JP5243718B2 (ja) * | 2004-04-09 | 2013-07-24 | 株式会社カネカ | 還元型補酵素q10およびカロチノイド類を含有した組成物 |
US20050226858A1 (en) * | 2004-04-09 | 2005-10-13 | Kaneka Corporation | Compositions containing reduced coenzyme Q10 and carotenoid |
JP4971597B2 (ja) * | 2005-03-23 | 2012-07-11 | 東海物産株式会社 | 抗酸化組成物 |
TW200722076A (en) * | 2005-03-29 | 2007-06-16 | Kaneka Corp | Composition for increasing anti-oxidation activity in blood |
US20060257385A1 (en) * | 2005-04-14 | 2006-11-16 | Rogovin Jarrow L | Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration |
JP2007001922A (ja) * | 2005-06-23 | 2007-01-11 | Asahi Kasei Pharma Kk | 透析患者における腎疾患改善剤、又は機能性食品 |
WO2007029730A1 (ja) * | 2005-09-06 | 2007-03-15 | Meiji Dairies Corporation | 老人性貧血を防止又は治療するためのアミノ酸組成物 |
JPWO2007034852A1 (ja) * | 2005-09-22 | 2009-03-26 | 株式会社カネカ | 延命用組成物及び寿命を延長する方法 |
JP4815593B2 (ja) * | 2006-03-14 | 2011-11-16 | 国立大学法人金沢大学 | 8−ヒドロキシデオキシグアノシンに特異的な結合性を有するdnaアプタマー |
TW200812567A (en) * | 2006-03-29 | 2008-03-16 | Kaneka Corp | Agent for improving nervous system cell functions |
WO2008069276A1 (ja) * | 2006-12-06 | 2008-06-12 | Kaneka Corporation | 癌治療剤および発癌抑制剤 |
US8337931B2 (en) * | 2008-06-23 | 2012-12-25 | Virun, Inc. | Compositions containing non-polar compounds |
EP2421367A4 (en) * | 2009-04-23 | 2012-05-23 | Univ Cincinnati | ALLANTOIN ADMINISTRATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND NEUROLOGICAL TRAUMATISM |
TWI492744B (zh) * | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US9668969B1 (en) | 2012-02-22 | 2017-06-06 | Arturo Solis Herrera | Methods of using QIAPINE |
WO2013148895A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular cross-linking system and method for sealing corneal wounds |
EP2830637A4 (en) | 2012-03-29 | 2016-03-16 | Cxl Ophthalmics Llc | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES RELATED TO OXIDATIVE STRESS |
EP2830627B1 (en) | 2012-03-29 | 2024-05-01 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4997M (ko) | 1965-04-26 | 1967-04-17 | ||
IT1157269B (it) * | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
JPH08768B2 (ja) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | 神経成長因子分泌誘導剤 |
US5648377A (en) * | 1993-12-21 | 1997-07-15 | Indena S.P.A. | Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
JP3889481B2 (ja) * | 1996-08-16 | 2007-03-07 | 株式会社カネカ | 医薬組成物 |
IT1290907B1 (it) * | 1997-01-31 | 1998-12-14 | Idi Farmaceutici Spa | Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare. |
JP3926888B2 (ja) * | 1997-05-27 | 2007-06-06 | 株式会社カネカ | コレステロール低下剤 |
CA2272971C (en) * | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
AU3930600A (en) | 1999-03-30 | 2000-10-16 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
US6740338B1 (en) * | 2000-01-20 | 2004-05-25 | Raj K. Chopra | Reduced form of Cenzyme Q in high bioavailability stable oral dosage form |
-
2002
- 2002-10-11 TW TW091123381A patent/TWI329513B/zh not_active IP Right Cessation
- 2002-10-15 KR KR1020047005109A patent/KR100629670B1/ko active IP Right Grant
- 2002-10-15 EP EP02772996A patent/EP1435234B1/en not_active Expired - Lifetime
- 2002-10-15 CN CNB028201248A patent/CN1297262C/zh not_active Expired - Lifetime
- 2002-10-15 JP JP2003535772A patent/JPWO2003032968A1/ja active Pending
- 2002-10-15 AU AU2002338186A patent/AU2002338186B2/en not_active Expired
- 2002-10-15 US US10/492,164 patent/US7015252B2/en not_active Expired - Lifetime
- 2002-10-15 AT AT02772996T patent/ATE481095T1/de not_active IP Right Cessation
- 2002-10-15 CA CA2461013A patent/CA2461013C/en not_active Expired - Lifetime
- 2002-10-15 DE DE60237697T patent/DE60237697D1/de not_active Expired - Lifetime
- 2002-10-15 WO PCT/JP2002/010641 patent/WO2003032968A1/ja active IP Right Grant
-
2005
- 2005-12-23 US US11/315,201 patent/US20060106116A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1297262C (zh) | 2007-01-31 |
JPWO2003032968A1 (ja) | 2005-02-03 |
WO2003032968A1 (fr) | 2003-04-24 |
AU2002338186B2 (en) | 2007-07-26 |
KR20040041675A (ko) | 2004-05-17 |
US20040248991A1 (en) | 2004-12-09 |
EP1435234A4 (en) | 2007-05-23 |
TWI329513B (en) | 2010-09-01 |
CN1568182A (zh) | 2005-01-19 |
EP1435234A1 (en) | 2004-07-07 |
CA2461013C (en) | 2010-05-04 |
ATE481095T1 (de) | 2010-10-15 |
DE60237697D1 (de) | 2010-10-28 |
US20060106116A1 (en) | 2006-05-18 |
CA2461013A1 (en) | 2003-04-24 |
US7015252B2 (en) | 2006-03-21 |
EP1435234B1 (en) | 2010-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100629670B1 (ko) | 산화 스트레스 저감 작용 조성물 | |
Bailey et al. | Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude | |
US7786175B2 (en) | Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation | |
KR20080049416A (ko) | 메타독신 및 마늘유를 유효성분으로 함유하는 알코올성지방간 및 지방간성 간염의 예방 및 치료용 약학 조성물 | |
KR20040091082A (ko) | 당뇨병용 조성물 | |
US20070009615A1 (en) | Compositions and methods for controlling glucose uptake | |
CA2982645C (en) | Composition for suppressing muscular fatty change | |
GB2368012A (en) | Preparation for the relief of inflammatory disease | |
JP2003171271A (ja) | 耐糖能異常用薬剤 | |
JP3908513B2 (ja) | 肝機能改善剤 | |
EP1784195A1 (de) | Pharmazeutische zusammensetzung, umfassend galaktose, selen, vitamin e und/oder phosphatidylcholin und pharmazeutische verwendungen von galaktose | |
US20100323031A1 (en) | Synergistic combination to enhance blood glucose and insulin metabolism | |
JP4974553B2 (ja) | アセトアルデヒド代謝促進剤 | |
EP1870095A1 (en) | Composition for increasing anti-oxidation activity in blood | |
WO2021205975A1 (ja) | 細胞老化抑制用組成物及び細胞老化を抑制する方法 | |
JP2015131849A (ja) | 耐糖能異常用医薬組成物及び飲食品 | |
KR20230009417A (ko) | 니코틴아미드 아데닌 디뉴클레오티드(nad) 농도상승제 | |
US3894153A (en) | Method of medical treatment of asthma | |
US20130029996A1 (en) | Special composition for the use thereof as a drug | |
EP4338731A1 (en) | Composition for increasing muscle mass | |
JP4896531B2 (ja) | 血中CoQ10量を増加させる医薬組成物 | |
JP2009155278A (ja) | 高ホモシステイン血症改善剤 | |
JP2019019084A (ja) | 組成物 | |
WO2022255276A1 (ja) | 社会的健康度の低下抑制又は改善用組成物 | |
JP4859314B2 (ja) | 潰瘍性大腸炎および/又はクローン病治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120907 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130903 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140901 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150819 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160818 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170818 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180903 Year of fee payment: 13 |